digital therapeutics

remote monitoring, digital therapeutics, dubai, diabetes

Credit: GluCare Diabetes Center

By Rachel McArthur 08:54 am October 21, 2020
A specialist clinic that’s claiming to be “the world’s first healthcare provider” to “employ remote continuous data monitoring” for diabetic patients has been officially opened in Dubai. Following a soft launch in September, GluCare Integrated Diabetes Center – which has been developed in the United Arab Emirates (UAE) with partners in Silicon Valley – offers remote continuous data monitoring as...
Two hands breaking a cigarette in half
By Mallory Hackett 12:46 pm October 8, 2020
The smoking-cessation digital-therapeutic app Quit Genius was found to be an effective treatment for people trying to stop smoking, especially when they are compared to individuals seeking out their own regimen, according to new research from JMIR Mental Health. The results from this study were only indicative for the short term, but researchers noted that a subsequent paper would be published...
By Dave Muoio 02:38 pm September 29, 2020
New data suggest that an Internet-delivered cognitive behavioral therapy (ICBT) intervention not only remained effective after 12 months among adolescents with obsessive-compulsive disorder, but seemed to have an even greater impact on their symptoms with time. Published last week in npj digital medicine, the analysis updated a previously reported three-month study with one-year data from the...
By MobiHealthNews 01:51 pm September 25, 2020
It's a bit of a pot pourri this week as the MobiHealthNews team shares some of what it's heard at a variety of (virtual, of course) industry events. First, host Jonah Comstock recaps what Apple announced at its product launch event last week, then Associate Editors Dave Muoio and Mallory Hackett discuss the Digital Therapeutics East event. Last, Managing Editor Laura Lovett and Jonah talk about...
By Mallory Hackett 01:01 pm September 18, 2020
Digital healths’ moment in the sun doesn’t appear to be ending anytime soon, and one area that is just beginning its journey into virtual care is the pharmaceutical industry.  In recent years, pharma has taken an interest in the digital health space, and even before the pandemic hit, experts from HealthXL expected 2020 to be a big year for digital therapeutics in pharma.  This morning at the DTx...
By Dave Muoio 03:35 pm September 17, 2020
The increased adoption of virtual care technologies during the COVID-19 public health emergency is fairly well documented by this point, but a widespread embrace of health technologies is providing a similar upswell on individual niches within the digital health landscape. One such group of beneficiaries are the companies working to develop, validate and distribute digital therapeutics. Speaking...
By Dave Muoio 04:53 pm September 11, 2020
International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. The treatment, referred to as CT-155, will be a mobile app built on Click's proprietary tech platform, the companies said. Employing cognitive and neurobehavioral...
By Jonah Comstock 10:54 am September 10, 2020
While some of the more obvious barriers to digital therapeutics adoption in Europe have come crashing down recently, adoption is still hampered by cultural momentum. That was the conclusion of a group of digital therapeutics stakeholders who presented at HIMSS & Health 2.0 Europe Digital Event today, in a session moderated by YourCoach Health chairman and COO Eugene Borukhovich. “Once a...
By Dave Muoio 10:48 am September 3, 2020
Biofourmis, a Boston-based predictive-care startup that's leaning more and more into digital therapeutics, has wrapped up $100 million in Series C financing. The raise was led by SoftBank Vision Fund 2, and also saw contributions from prior backers Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. With this major jump from last May's $35 million Series B, the company is now...
By Dave Muoio 01:40 pm August 31, 2020
Pear Therapeutics highlighted data today from two studies of a digital cognitive behavioral therapy that acted as the precursor for Somryst, the prescription digital therapeutic for adults with chronic insomnia that was the first to pass through the FDA's Pre-Cert pilot pathway. The first, a randomized controlled trial of 1,149 Australian adults with insomnia and depressive symptoms, suggested...